CEBPA and acute myeloid leukemia: The definition of AML with biallelic mutation of CEBPA in the revised fourth edition of the WHO Classification has been redefined to include single mutations located in the bZIP region of CEBPA by the WHO-HAEM5 and replaced with AML with in-frame bZIP CEBPA mutations by ICC 2022 [8,9].